About WellSpan Health
Services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Medications for Hepatitis C treatment; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State Substance use treatment agency
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; SAMHSA funding/block grants
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Interim services for clients; Outreach to persons in the community; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Drug or alcohol urine screening; Metabolic syndrome monitoring; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV)
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Self-help groups; Housing services; Assistance with obtaining social services; Mentoring/peer support
Education and Counseling Services
Substance use disorder education; Individual counseling; Group counseling
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Mental health services; Transportation assistance; Suicide prevention services
Type of Care
Substance use treatment; Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment; Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Type of Opioid Treatment
Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone
Pharmacotherapies
Acamprosate (Campral®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Buprenorphine (extended-release, injectable); Naltrexone (oral); Naltrexone (extended-release, injectable); Medications for Hepatitis C treatment; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention; Cognitive behavioral therapy; Motivational interviewing; Matrix Model; Relapse prevention; Substance use disorder counseling; Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public)
Private non-profit organization
License/Certification/Accreditation
State Substance use treatment agency
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs; SAMHSA funding/block grants
Assessment/Pre-treatment
Comprehensive mental health assessment; Comprehensive substance use assessment; Interim services for clients; Outreach to persons in the community; Complete medical history/physical exam; Screening for tobacco use; Screening for substance use; Screening for mental disorders
Testing
Drug or alcohol urine screening; Metabolic syndrome monitoring; Testing for Hepatitis B (HBV); Testing for Hepatitis C (HCV)
Transitional Services
Aftercare/continuing care; Discharge Planning; Naloxone and overdose education; Outcome follow-up after discharge
Recovery Support Services
Self-help groups; Housing services; Assistance with obtaining social services; Mentoring/peer support
Education and Counseling Services
Substance use disorder education; Individual counseling; Group counseling
Facility Smoking Policy
Smoking not permitted
Age Groups Accepted
Young Adults; Adults
Gender Accepted
Female; Male
Language Services
Sign language services for the deaf and hard of hearing
Facility Vaping Policy
Vaping not permitted
Ancillary Services
Mental health services; Transportation assistance; Suicide prevention services
